PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 113.20
Bid: 113.00
Ask: 113.60
Change: 2.00 (1.80%)
Spread: 0.60 (0.531%)
Open: 112.00
High: 113.40
Low: 110.60
Prev. Close: 111.20
PZC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

27 Apr 2021 07:00

RNS Number : 6451W
PZ CUSSONS PLC
27 April 2021
 

Continued momentum in an exceptional year - and investing in building brands for life

 

PZ Cussons plc ("PZ Cussons" or the "Group") today issues the following trading update in respect of its third quarter, ended 27 February 2021.

 

Highlights

 

· Q3 revenue (1) growth of 4.7%, up to £145.3m

· All Regions grew revenue (1) and profit versus the prior year

· Must Win Brands revenue (1) increased 12%, fuelling overall performance

· Carex in the UK and Morning Fresh in Australia and Nigeria performed strongly, with both brands continuing to meet the evolving hygiene needs of our consumers

· Strong performance amongst our other Must Win Brands

- Sanctuary Spa delivered strong double-digit growth, thanks to increased bricks and mortar retail sales and exceptional online performance

- Original Source returned to growth in the quarter

- Cussons Baby grew in both Indonesia and Nigeria, continuing the year to date trend

· Continued investment behind our brands, strategic capabilities and operations, with Media & Consumer spend in the quarter up approximately 30% on the prior year

· Balance Sheet remains robust. Net Debt, of £35m, is down from £116m a year ago

 

Quarter 3

£m

Growth vs. Q3 FY20

(reported)

Growth vs. Q3 FY20

(constant currency)

Europe & Americas

44.4

8.1%

8.7%

Asia Pacific

47.2

1.4%

2.6%

Africa

52.7

(7.0)%

3.2%

Central

1.0

16.9%

18.8%

Group

145.3

0.1%

4.7%

 

(1) Revenue growth is quoted on a constant currency basis, unless otherwise stated

 

Outlook

Despite continued market volatility, we remain on track to perform in line with the current range of market expectations for full year FY21.

 

Jonathan Myers, Chief Executive Officer, commented "Our third quarter results maintained the renewed momentum of our business despite the quarter ending with the anniversary of the start of the global COVID-19 pandemic. The encouraging growth was broad-based, with all Regions delivering top and bottom-line growth, enabling the Group to deliver operating margins ahead of Q3 last year, while continuing to increase investment behind our Must Win Brands and new strategic capabilities. In the final quarter of this current financial year, as some of our brands come up against strong levels of demand in the base period, we intend to continue increasing investment behind building our brands and capabilities, to maintain momentum as we move to more normal comparatives.

 

Looking ahead, we will continue to proactively navigate the volatility of the pandemic, the competitive landscape and commodity cost headwinds, but at the same time remain focused on executing the initial phase of our new strategy - Building Brands for Life, Today and for Future Generations.

 

We continue to take the appropriate steps to safeguard the health and wellbeing of our employees during the pandemic, and to ensure our supply chain remains resilient and fully operational. I'd like to thank our employees in all our markets for their continued dedication to PZ Cussons and our consumers."

 

FY21 reporting timetable

In light of the impact of COVID-19 on reporting and audit procedures, and further to the Financial Conduct Authority's (FCA) policy statement issued on 27 January 2021, the Group confirms it intends to report preliminary results for the year to 31 May, in September. The Group also intends to issue a pre-close trading statement, as soon after the year end as is practical.

 

Notes to Editors

Sales data is for the 13 weeks to 27 February 2021

Figures are unaudited, and not subject to review by the Group's auditors

 

Cautionary note regarding forward-looking statements

This announcement contains certain forward-looking statements relating to expected or anticipated results, performance or events. Such statements are subject to normal risks associated with the uncertainties in our business, supply chain and consumer demand along with risks associated with macro-economic, political and social factors in the markets in which we operate. Whilst we believe that the expectations reflected herein are reasonable based on the information we have as at the date of this announcement, actual outcomes may vary significantly owing to factors outside the control of the Group, such as cost of materials or demand for our products, or within our control such as our investment decisions, allocation of resources or changes to our plans or strategy. The Group expressly disclaims any obligation to revise forward-looking statements made in this or other announcements to reflect changes in our expectations or circumstances. No reliance may be placed on the forward looking statements contained within this announcement.

 

For further enquiries, please contact

 

Investors

Sarah Pollard, PZ Cussons plc - Chief Financial Officer

0161 435 1000

Media

Tim Linacre / Guy Scarborough / Bryn Woodward - Instinctif

020 7457 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUNSBRAAUSUAR
Date   Source Headline
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding
20th Dec 20222:40 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:55 pmRNSDirector/PDMR Shareholding
24th Nov 20223:24 pmRNSResult of AGM
24th Nov 20227:00 amRNSDirectorate Change
21st Nov 20223:21 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNew Credit Facility Linked to B Corp Ambitions
18th Oct 20223:52 pmRNSDirector/PDMR Shareholding
14th Oct 20227:00 amRNSPublication of Annual Report and Notice of AGM
27th Sep 202210:52 amRNSDirector/PDMR Shareholding
23rd Sep 20223:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNS2022 Full Year Results
21st Sep 202210:06 amRNSDirector Declaration
2nd Sep 202210:29 amRNSHolding(s) in Company
19th Aug 202210:05 amRNSDirector/PDMR Shareholding
29th Jul 20229:46 amRNSDirector/PDMR Shareholding
20th Jul 20223:21 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update
21st Jun 20224:10 pmRNSDirector/PDMR Shareholding
20th May 202210:30 amRNSFurther re 2021 AGM voting results
19th May 20225:45 pmRNSDirector/PDMR Shareholding
21st Apr 202210:30 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Mar 202210:00 amRNSDirector/PDMR Shareholding
23rd Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:15 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSAcquisition of Childs Farm
21st Feb 202211:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:25 amRNSDirector/PDMR Shareholding
11th Feb 20229:15 amRNSBoard update
9th Feb 20227:00 amRNSHalf-year Report
19th Jan 202210:10 amRNSDirector/PDMR Shareholding
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding
9th Dec 20219:38 amRNSNotice of Interim Results
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.